Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2019 · 30 citations · 23 references
Veterinary MedicineInfectious DiseasesPharmacologyImmunizationImmunotherapyVaccinologyTuberculosis PharmacotherapyTuberculosis VaccinationVaccinationVaccine DeliveryVaccine SafetyVaccine-based ImmunotherapyDouble-blind TrialsMultidrug-resistant Tuberculosis TreatmentMycobacterial DiseaseNew Tuberculosis VaccinesTherapeutic Vaccine DevelopmentTherapeutic Vaccine EfficacyTherapeutic Vaccine TrialsUnmet Health Need
Immunotherapy of tuberculosis (TB) to shorten treatment duration represents an unmet medical need. Orally delivered, tableted TB vaccine (V7) containing heat-killed Mycobacterium vaccae (NCTC 11659) has been demonstrated in prior clinical studies to be safe and fast-acting immune adjunct. The outcome of Phase III trial of V7 containing 10 µg of hydrolyzed M. vaccae was evaluated in 152 patients randomized at 2:1 ratio: V7 (N = 100), placebo (N = 52). Both arms received conventional 1st or 2nd line TB drugs co-administered with daily pill of V7 or placebo. After one month mycobacterial clearance was observed in 68% (P < 0.0001) and 23.1% (P = 0.04) of patients on V7 and placebo. Stratified conversion rates in V7 recipients with drug-sensitive and multidrug-resistant TB were 86.7% and 55.6% vs 27.2% and 15% in placebo. Patients on V7 gained on average 2.4 kg (P < 0.0001) vs 0.3 kg (P = 0.18) in placebo. Improvements in hemoglobin levels, erythrocyte sedimentation rate and leukocyte counts were significantly better than in controls. Liver function tests revealed that V7 can prevent chemotherapy-induced hepatic damage. Oral M. vaccae is safe, can overcome TB-associated weight loss and inflammation, reduce hepatotoxicity of TB drugs, improve sputum conversion three-fold OR 3.15; 95%CI (2.3,4.6), and cut treatment length by at least six-fold. Longer follow-up studies might be needed to further substantiate our findings (Clinicaltrials.gov: NCT01977768).
23
A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis
Andrew Nunn, Patrick Phillips, Sarah Meredith et al. · New England Journal of Medicine · 2019 · 402 citations · Full text
Iron Deficiency and Anemia Predict Mortality in Patients with Tuberculosis3
Sheila Isanaka, Ferdinand Mugusi, Willy Urassa et al. · Journal of Nutrition · 2011 · 157 citations · Full text
Anali Conesa-Botella, Graeme Meintjes, Anna K. Coussens et al. · Clinical Infectious Diseases · 2012 · 71 citations · Full text